Friday, February 26, 2010

If spam equals revenue...

So as you may or may not remember I have been frequenting Fool.com. I have already discussed how they recommended Rosetta Stone (RST),which is up 27% from just yesterday.

While that pick was a more formal recommendation, they also offer informal ones to anyone who wanders their way over to fool.com and reads the free articles. I thought it was interesting to note that one of the picks was for Pfizer, the company who manufactures the product our spam boxes know and love.

Now don't get me wrong, they talk about a whole lot of factors in their promotion of Pfizer, which are probably justifiable. But that leads me to a question.

Should I invest in a company like Pfizer?

I know they do more then just make Viagra, but that is hard to overlook when my email boxes are loaded with thousands of Viagra related spam. Should traders be concerned with moral issues, or should they focus on making money?

As for myself I am torn.

Luckily I do not have to invest in Pfizer because the plan was to purchase only the official recommended companies, and this is unofficial. But what if Pfizer becomes the official pick?

We will just have to wait and see where my conscience takes me.

"Wait, you like girls and money! Your freaking me out..."

Hopefully soon their will be some real action to write about.




-tCT

1 comment:

  1. There are the things in life I do because "otherwise someone else will," and there are those you do because otherwise someone else won't. Things like investing in corrupt companies falls in the former category. Giving the money I earn from that to Ron Paul's campaign falls in the second.

    ReplyDelete